- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 350352, 7 pages
In Vivo Testing of MicroRNA-Mediated Gene Knockdown in Zebrafish
1School of Biological Sciences, University of Auckland, Private Bag 92019, Auckland Mail Centre, Auckland 1142, New Zealand
2Green Lane Paediatric and Congenital Cardiac Service, Auckland City Hospital/Starship Children’s Hospital, Auckland, New Zealand
3Department of Obstetrics and Gynaecology, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
4LabPLUS, Auckland City Hospital, P.O. Box 110031, Auckland Mail Centre, Auckland 1142, New Zealand
Received 15 September 2011; Revised 25 November 2011; Accepted 25 November 2011
Academic Editor: Kurt Bürki
Copyright © 2012 Ivone Un San Leong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The zebrafish (Danio rerio) has become an attractive model for human disease modeling as there are a large number of orthologous genes that encode similar proteins to those found in humans. The number of tools available to manipulate the zebrafish genome is limited and many currently used techniques are only effective during early development (such as morpholino-based antisense technology) or it is phenotypically driven and does not offer targeted gene knockdown (such as chemical mutagenesis). The use of RNA interference has been met with controversy as off-target effects can make interpreting phenotypic outcomes difficult; however, this has been resolved by creating zebrafish lines that contain stably integrated miRNA constructs that target the desired gene of interest. In this study, we show that a commercially available miRNA vector system with a mouse-derived miRNA backbone is functional in zebrafish and is effective in causing eGFP knockdown in a transient in vivo eGFP sensor assay system. We chose to apply this system to the knockdown of transcripts that are implicated in the human cardiac disorder, Long QT syndrome.
The zebrafish has become an attractive model for human disease modeling as there are a large number of orthologous genes in the zebrafish genome , and the encoded proteins exhibit similar functions to those expressed in humans. The methods that are available to manipulate zebrafish gene expression are limited, but principal among these methods is morpholino-based antisense technology that enables transient downregulation in order to study the effects of reduced gene expression during early vertebrate development. To create stable mutant fish lines, chemical mutagenesis (ENU) is the method of choice; however, this forward genetics approach is driven by phenotypic outcomes and is not able to target and knock down specific genes. In contrast, zinc finger nucleases (ZFNs) are an emerging technology that has proved successful in targeted gene knockdown in zebrafish [2–4]. Unfortunately, the design and production process is arduous and requires specialised knowledge, thus restricting its use in the wider research community. ZFNs also do not offer the option of causing gene knockdown in a tissue-specific manner or of providing conditional gene knockdown (the ability to turn on or off gene knockdown). This latter outcome would provide a more subtle disease model that is suited for studying late onset disorders, and it is in this context that RNA interference may offer a way forward.
The use of RNA interference (RNAi) technology has proven to be a very useful tool in disease modelling in mammalian systems . The use of different promoters has allowed for tissue-specific expression of miRNAs, therefore restricting gene knockdown to targeted areas/organs, and also conditional knockdown with the use of Tet-on promoters (the Cre/loxP system is used in mice) . In brief, small noncoding RNAs enable fine-tuning gene expression at the posttranscriptional level during development, apoptosis, and metabolism [7, 8]. These noncoding RNAs cause cleavage/degradation, or the stalling of translation, of a target mRNA (refer to  for a detailed review) and can be synthetically created to cause gene knockdown. miRNAs can be expressed by a DNA-based vector system in which miRNA transcripts, consisting of a double-stranded hairpin structure, are processed by several endonucleases to form 22 nucleotide mature miRNAs, which then form a complex with the RNA-induced silencing complex (RISC) to carry out targeted gene silencing.
The use of RNAi in zebrafish has been controversial as there are varying opinions regarding its effectiveness, and specificity, in causing gene knockdown. It has been suggested that the expression of miRNAs in zebrafish embryos leads to off-target/toxic phenotypes due to flooding the endogenous miRNA pathway [9, 10]. However, transgenic zebrafish lines have been constructed that express miRNAs designed to target desired genes of interest with no apparent toxic effects. Dong et al. and Ho et al. successfully used miRNAs to mediate gene knockdown in zebrafish and have created a conditional knockdown model  and a heritable gene knockdown fish line .
Given the above background, we have considered that RNAi-based technology might allow the development of zebrafish models of heritable cardiac disorders such as Long QT syndrome (LQTS). This syndrome is a congenital cardiac disorder, which is characterized by a prolonged QT-interval that can lead to fatal arrhythmias. Of the many genes (encoding for cardiac ion channels/scaffolding proteins) implicated in LQTS, we have focussed on the KCNH2 gene, which encodes for the α-subunit of the rapid delayed inward rectifier potassium channel and is vital for the repolarisation phase in the cardiac cycle. The dominant mutations that have been detected in LQTS type 2 patients encompass nonsense mutations, as well as exon deletions and duplications, which suggest that haploinsufficiency of KCNH2 plays a role in the manifestation of disease [13, 14].
Two KCNH2-type genes have been identified in zebrafish, termed zerg-2 and zerg-3 [1, 2]. The former appears to be an orthologue of the human KCNH2 gene, while the latter appears to encode a protein with KCNH2 function but is an orthologue of the human KCNH6 gene, which is another potassium channel that belongs to the same family as KCNH2. Critically, the (unregulated) knockdown of both zebrafish genes leads to a cardiac phenotype (bradycardia, atrioventricular block, and prolonged QT interval) that mimics the phenotype seen in patients with LQTS [1, 3]. Here, we show that a commercially available miRNA vector system is capable of mediating gene knockdown in zebrafish. We evaluate this approach in a transient in vivo method that targets various regions of the zebrafish zerg-2 and zerg-3 gene transcripts as a prelude to mimicking the haploinsufficiency of zerg-2 and zerg-3 in zebrafish in a stable transgenic fish line and to ensure that the custom-designed miRNAs are able to cause the knockdown of their intended targets.
2. Materials and Methods
2.1. Zebrafish Husbandry
Wild-type zebrafish (Danio rerio) were bred and maintained as described by Tang et al. .
2.2. Creation of pcDNA 6.2 GW/DsRed Express-miR
Linearised pcDNA 6.2 GW/EmGFP-miR was recircularised by the insertion of synthesised double-stranded oligonucleotides (dsOligo) containing the same cohesive ends as the miRNA cloning site. Two BsmBI restriction enzyme sites were included at both 5′ and 3′ ends. Single-stranded DNAs (ssOligos) were synthesised (Invitrogen) and annealed and cloned into the pcDNA 6.2 GW/EmGFP-miR vector as described below. The DsRed Express coding region was amplified by PCR from the pTRE-Tight-BI-DsRed Express vector (Clontech). The EmGFP coding region was removed from the pcDNA 6.2 GW/EmGFP-miR vector by DraI restriction enzyme digestion, treated with calf intestinal phosphatise, and purified. The amplified DsRed Express coding region was cloned into the pcDNA 6.2 GW vector and bidirectionally sequenced to confirm the correct orientation of DsRed Express.
2.3. miRNA Design and Construction
miRNA target sites were designed using the BLOCK-iT RNAi Designer (Invitrogen) under the miR RNAi design option. The entire zerg-2 (Genbank ID: HM209079) and zerg3 (Ensembl ID: ENSDARP00000085242) gene transcript sequences were used for the design process, and targets were chosen based on location (close to or within the 3′ UTR) and the score the designer programme gave to each target site. The top and bottom ssOligos (Table 1) of the mature miRNA were synthesised (Invitrogen) and cloned into the pcDNA 6.2-GW/dsRed-miR expression vector according to the manufacturer’s instructions.
2.4. Construction of eGFP Sensor Vector
As the pCS2+ vector does not contain an eGFP reporter gene, one had to be inserted into the vector before the eGFP sensor vector could be used. The Kozak sequence and the eGFP coding region was excised from pT2AL200R150G (a gift from Dr Koichi Kawakami, National Institute of Genetics) using BamHI and ClaI restriction enzymes. The pCS2+ vector was restriction enzyme digested with BamHI and ClaI and the eGFP coding region was cloned into the linearised vector (Figure 1).
The 22 nucleotides that form the mature miRNA (Table 1) were used as the target site and the top and bottom ssOligos were synthesized (Invitrogen). The ssOligos were annealed according to the manufacturer’s instructions for the construction of the miRNA vectors, and this was ligated downstream of the eGFP reporter gene in the pCS2+ eGFP vector. The pCS2+ eGFP vector was linearized with XhoI and XbaI to create sites for ligation.
2.5. Microinjection of Zebrafish and In Vivo Assay
Both miR RNAi and the target vectors were linearised using EagI and XhoI (miRNA vector) and BssHII (eGFP sensor vector). The digested products were gel-purified using MinElute Gel Extraction Kit (Qiagen). In vitro transcription was carried out using the mMESSAGE mMACHINE kit (Ambion, Inc), and transcribed mRNAs were purified using the LiCl precipitation method (according to manufacturer’s instructions). RNA quality was determined by gel electrophoresis and quantified using a Nanodrop ND-1000 spectrophotometer (NanoDrop Technologies, Inc).
1 nL of solution containing 300 pg of miRNA and 50 pg of eGFP sensor mRNA was microinjected into 1-2-cell stage embryos (or 300 pg of scrambled sequence miRNA, which was designed not to target any known zebrafish transcript, with 50 pg of eGPF sensor mRNA). 24 hours post-fertilization (hpf) embryos were observed and imaged using the Zeiss Axiovert S100 microscope. All images were taken from Nikon Eclipse Ti inverted microscope. To quantify the raw fluorescence output, each group of embryos were loaded into a 96-well optical bottom plates in triplicate and the fluorescence was quantified using an EnVision Multilabel Microplate Reader (PerkinElmer, Inc). The settings were as follows: 485 nm excitation filter and 535 nm emission filter with a constant incubation temperature of 28°C. The raw fluorescence was averaged and the difference in fluorescence was compared to determine the efficiency of each miRNA.
2.6. Data Analysis
Fluorescence readings were expressed in arbitrary fluorescence units. Wells with only E3 medium were used as a measure of background fluorescence. The mean background fluorescence was subtracted from the mean of the embryo containing wells. The readings were then normalized against the negative control embryos and expressed as a percentage. The normalized fluorescence percentages were analysed using one-way ANOVA.
3. Results and Discussion
3.1. miRNA Design
The mechanism behind miRNA-mediated gene knockdown is still widely discussed (mechanisms ranging from translation stalling to mRNA cleavage), so it was considered prudent to design several miRNAs that targeted different regions in the two genes of interest. To mediate gene-specific knockdown in zebrafish, four different miRNAs were designed against each of the two zebrafish kcnh2 genes (zerg-2 and zerg-3). Each target site had a five-star ranking based on the ranking system using the Invitrogen Block-iT RNAi Designer, which ensured that the designed miRNAs would form the most effective RNAi molecules. At least one of the miRNA targets was located within the 3′ untranslated region (3′ UTR), while the others were located at various locations in the open reading frame (ORF; Figure 1(a)). Dong et al. have shown that miRNA target sites located at the 3′ UTR are more effective at causing gene knockdown compared to miRNA sites in the middle of an ORF , and our own laboratory has shown that it is also the case with the Block-iT system (data not shown). It has been suggested that this bias in efficiency is due to the translational machinery displacing bound miRNAs in the ORF regions as the machinery moves from the cap-binding complex to the ORF [7, 16]. Despite this, it has also been found that many miRNA target sites are found within ORFs . Therefore, it was thought that gene expression knockdown could be maximized by targeting four different locations within each transcript.
3.2. Transient In Vivo Testing of the Efficacy of Individual miRNAs
The use of miRNA in mediating gene knockdown in zebrafish has been successfully achieved by Dong et al. and Ho et al. [11, 12]. The miRNA backbone used by Dong et al. was an endogenous zebrafish miRNA that is an orthologue of the mammalian miR-30e . Here we have used a commercially available miRNA backbone that is based on the endogenous mouse miR-155, which has previously been shown to be effective in causing gene knockdown in mammalian cell lines . Despite the fact that Dong et al.  found the efficiency of the zebrafish orthologue of miR-155 to be less than miR-30e, the data did not suggest that the mouse miR-155 backbone would not be effective in causing gene knockdown in zebrafish.
It was decided to validate the Block-iT miRNA system in the zebrafish and also to test the effectiveness of the custom-designed miRNAs by using a transient in vivo sensor assay. If the custom-designed miRNAs effectively caused knockdown in the transient in vivo sensor assay, then the miRNAs could be stably incorporated into the zebrafish genome to create transgenic fish lines. The transient in vivo sensor assay involved cloning the putative miRNA target sites into the 3′ UTR of a reporter/sensor gene [9, 18, 19] (Figure 1(a)). Each miRNA target was inserted downstream of an eGFP reporter gene (eGFP sensor), and both the miRNA and their respective sensor were coinjected into one-cell stage embryos. The duration of this assay was restricted by the half-life of the capped miRNA transcripts, and the embryos were screened for eGFP expression at 24 hours post-fertilization (hpf). At this stage, eGFP and DsRed expression could be detected and the effect of the miRNAs assessed. In the event of targeted knockdown, eGFP fluorescence would be expected to decrease (Figure 1(b)). As the miRNA target site was linked to eGFP, the emGFP reporter gene in the Block-iT expression vector was replaced with the DsRed Express reporter gene. The assessment of the assay was based solely on the level of eGFP expression produced by the injected embryos, and any phenotypic outcomes (i.e., heart rate, electrocardiogram) were not scored.
All eight miRNAs were able to decrease eGFP expression (Figures 2 and 3). Zerg-2 miRNA 4 caused the greatest level of eGFP expression knockdown (approximately 88%) with zerg-2 miRNA 1 and 2 causing approximately 69–73% eGFP knockdown (Figure 2). Zerg-2 miRNA 3 was only able to cause 32% knockdown (Figure 2). Zerg3 miRNA 3 caused the greatest level of eGFP knockdown (approximately 98%) with zerg3 miRNA 1 and 4 causing approximately 77–90% knockdown (Figure 3); the extent of knockdown caused by Zerg-3 miRNA 2 was not statistically significant. The results from the in vivo sensor assay demonstrate that the Block-iT miRNA backbone is functional in zebrafish and the custom-designed miRNA is capable of causing gene knockdown as assessed by the in vivo sensor system.
3.3. Assessment of Off-Target Effects
One of the main issues in using RNAi knockdown technology is the possibility of causing off-target gene knockdown. In zebrafish, this has proven to be one of the main downfalls of using RNAi as it has been found that the miRNA is vital for early development and the introduction of exogenous miRNA might cause competition for miRNA processing machinery [9, 10]. This in turn leads to a decrease in endogenous miRNA which is needed to clear maternal mRNA during development. Zhao et al. have reported phenotypes that are associated with toxic effects from the use of RNAi in zebrafish, which included the loss of the midbrain-hindbrain boundary in siRNA-injected embryos . In the current study there has been no evidence of the loss of the midbrain-hindbrain boundary; however, it cannot be ruled out that there is tissue-specific toxicity that is not readily apparent (Figure 1(c)).
The transient in vivo eGFP sensor assay has shown that the Block-iT is functional in the zebrafish system and also that the designed miRNAs are capable of causing knockdown at the protein level. These pilot data lay the foundation for constructing transgenic zebrafish expressing the miRNAs used here in order to model LQTS.
The authors acknowledge the financial support of the Maurice and Phyllis Paykel Trust and the School of Biological Sciences of The University of Auckland.
- K. Dooley and L. I. Zon, “Zebrafish: a model system for the study of human disease,” Current Opinion in Genetics and Development, vol. 10, no. 3, pp. 252–256, 2000.
- Y. Doyon, J. M. McCammon, J. C. Miller et al., “Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases,” Nature Biotechnology, vol. 26, no. 6, pp. 702–708, 2008.
- J. E. Foley, J.-R. J. Yeh, M. L. Maeder et al., “Rapid mutation of endogenous zebrafish genes using zinc finger nucleases made by oligomerized pool ENgineering (OPEN),” PLoS One, vol. 4, no. 2, Article ID e4348, 2009.
- M. L. Maeder, S. Thibodeau-Beganny, A. Osiak et al., “Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification,” Molecular Cell, vol. 31, no. 2, pp. 294–301, 2008.
- K. Podolska and P. Svoboda, “Targeting genes in living mammals by RNA interference,” Briefings in Functional Genomics, vol. 10, no. 4, pp. 238–247, 2011.
- A. Kleinhammer, J. Deussing, W. Wurst, and R. Kühn, “Condition RNAi in mice,” Methods, vol. 53, pp. 142–150, 2010.
- D. P. Bartel, “MicroRNAs: target recognition and regulatory functions,” Cell, vol. 136, no. 2, pp. 215–233, 2009.
- J. Krol, I. Loedige, and W. Filipowicz, “The widespread regulation of microRNA biogenesis, function and decay,” Nature Reviews Genetics, vol. 11, no. 9, pp. 597–610, 2010.
- A. J. Giraldez, Y. Mishima, J. Rihel et al., “Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs,” Science, vol. 312, no. 5770, pp. 75–79, 2006.
- X. F. Zhao, A. Fjose, N. Larsen, J. V. Helvik, and Ø. Drivenes, “Treatment with small interfering RNA affects the microRNA pathway and causes unspecific defects in zebrafish embryos,” The FEBS Journal, vol. 275, no. 9, pp. 2177–2184, 2008.
- Y. L. Ho, Y. H. Lin, W. Y. Tsai, F. J. Hsieh, and H. J. Tsai, “Conditional antisense-knockdown of zebrafish cardiac troponin C as a new animal model for dilated cardiomyopathy,” Circulation Journal, vol. 73, no. 9, pp. 1691–1697, 2009.
- M. Dong, Y. F. Fu, T. T. Du et al., “Heritable and lineage-specific gene knockdown in Zebrafish embryo,” PLoS One, vol. 4, no. 7, Article ID e6125, 2009.
- T. T. Koopmann, M. Alders, R. J. Jongbloed et al., “Long QT syndrome caused by a large duplication in the KCNH2 (HERG) gene undetectable by current polymerase chain reaction-based exon-scanning methodologies,” Heart Rhythm, vol. 3, no. 1, pp. 52–55, 2006.
- C. A. Eddy, J. M. MacCormick, S. K. Chung et al., “Identification of large gene deletions and duplications in KCNQ1 and KCNH2 in patients with long QT syndrome,” Heart Rhythm, vol. 5, no. 9, pp. 1275–1281, 2008.
- R. Tang, A. Dodd, D. Lai, W. C. McNabb, and D. R. Love, “Validation of zebrafish (Danio rerio) reference genes for quantitative real-time RT-PCR normalization,” Acta Biochimica et Biophysica Sinica, vol. 39, no. 5, pp. 384–390, 2007.
- D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004.
- K. H. Chung, C. C. Hart, S. Al-Bassam et al., “Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155,” Nucleic Acids Research, vol. 34, no. 7, article e53, 2006.
- T. T. Du, Y. F. Fu, M. Dong et al., “Experimental validation and complexity of miRNA-mRNA target interaction during zebrafish primitive erythropoiesis,” Biochemical and Biophysical Research Communications, vol. 381, no. 4, pp. 688–693, 2009.
- A. S. Flynt, N. Li, E. J. Thatcher, L. Solnica-Krezel, and J. G. Patton, “Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate,” Nature Genetics, vol. 39, no. 2, pp. 259–263, 2007.